Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140725
Status:
COMPLETED
Last Update Posted:
2008-10-16
First Post:
2005-08-31
Brief Title:
Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus HBV
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline